India's Emcure Pharma extends gains on Q4 profit jump
** Shares of India's Emcure Pharmaceuticals EMCU.NS extends gains, last up 10% ** Drugmaker's Q4 consol PAT surged 63% y/y, rev rose ~20% ** Stock set to rise for third straight session, over this period it has gained 21% ** Trading vols 303k shares, twice the 30-day avg ** So far this year, stock down over 11% (Reporting by Hritam Mukherjee in Bengaluru) ((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees